Odyssey Health (ODYY) Stock Price, News & Analysis

Company Overview

Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.0075 to $0.0150
• 50-Day Range: $0.01 to $0.04
• 52-Week Range: $0.01 to $0.06
• Volume: 277,050 shs
• Average Volume: 72,485 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ODYY Stock Analysis - Frequently Asked Questions

How have ODYY shares performed this year?

Odyssey Health's stock was trading at $0.0266 on January 1st, 2025. Since then, ODYY shares have decreased by 52.3% and is now trading at $0.0127.

How do I buy shares of Odyssey Health?

Shares of ODYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Odyssey Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Odyssey Health investors own include Allkem (OROCF), Vislink Technologies (VISL), HEXO (HEXO), Meta Platforms (META), NightHawk Biosciences (NHWK), Virgin Galactic (SPCE) and Visium Technologies (VISM).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ODYY
• CIK: 1626644
• Web: theodysseygroupinternational.com
• Phone: (702) 780-6559
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A